BMC Gastroenterology · 2024 · 17 citations · 30 references
MedicineRadiologyDiagnostic ImagingHepatologyUltrasonographyBiomarkers Of Liver InjuryChronic Liver DiseaseHepatobiliary ImagingHepatobiliary PathologyLiver DiseaseMetabolic Liver DiseaseInterpretation Of Liver Function TestsLiver Fibrosis BiomarkersMetabolic Dysfunction-associated Steatotic Liver Disease FibrosisNon-invasive ExaminationNonalcoholic Fatty Liver Disease AssessmentRetrospective Case AscertainmentRetrospective Case StudySteatosis Biomarkers
OBJECTIVES: To determine how fetuin-A contributes to diagnosing and assessing MASLD severity. METHODS: Fifty MASLD patients and fifty healthy control participants were involved in this retrospective case-control research. Abdominal ultrasonography, fibroscan with controlled attenuated parameter scan (CAP scan), laboratory investigation (including fetuin-A assessment), clinical examination, and history-taking were performed on every case. RESULTS: Fetuin-A level was considerably higher in the Cases group (1154.85 ± 629.89) than in the Control group (505.29 ± 150.4) (p < 0.001). Fetuin-A had significant validity in the prediction of MASLD at a cut-off > 702.5 with 82% sensitivity, 90% specificity, and 86% overall accuracy. CONCLUSION: One possible marker for MASLD diagnosis could be fetuin-A. Furthermore, a substantial association between such marker and the severity of the disease as it revealed a significant correlation with ultrasound grading and fibroscan with controlled attenuated parameters. Trial registration 1- Pan African Clinical Trial Registry. Unique Identifying number/registration ID: PACTR202309644280965. URL: https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=26860 . Registration Approval date: 21/09/2023. 2- ClinicalTrials.gov. Unique Identifying number /registration ID: NCT06097039. URL: https://clinicaltrials.gov/study/NCT06097039?cond=NCT06097039&rank=1 . Registration Approval date: 25/10/2023.
30
Paul Angulo, Jason M. Hui, Giulio Marchesini et al. · Hepatology · 2007 · 3.2K citations · Full text
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu et al. · Hepatology · 2023 · 2.9K citations · Full text
The utility of radiological imaging in nonalcoholic fatty liver disease
Sherif Saadeh, Zobair M. Younossi, Erick M. Remer et al. · Gastroenterology · 2002 · 2.1K citations